Apollomics, Inc. (NASDAQ:APLMW) Short Interest Down 55.0% in December

by · The Cerbat Gem

Apollomics, Inc. (NASDAQ:APLMW – Get Free Report) was the target of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 68,200 shares, a decrease of 55.0% from the November 30th total of 151,500 shares. Based on an average trading volume of 79,400 shares, the short-interest ratio is currently 0.9 days.

Apollomics Stock Performance

APLMW stock traded up $0.00 during midday trading on Friday, reaching $0.01. 6,898 shares of the company’s stock traded hands, compared to its average volume of 52,916. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.04. The firm’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.01.

Apollomics Company Profile

(Get Free Report)

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.

Featured Articles